Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.

Esteban F, Redondo M, Delgado M, Garrido F, Ruiz-Cabello F.

Br J Cancer. 1996 Dec;74(11):1801-4.

2.

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.

Esteban F, Concha A, Delgado M, Pérez-Ayala M, Ruiz-Cabello F, Garrido F.

Br J Cancer. 1990 Dec;62(6):1047-51.

3.

[Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].

Esteban F, Concha A, Delgado M, Ruiz-Cabello F, Garrido F.

Acta Otorrinolaringol Esp. 1990 Nov-Dec;41(6):359-68. Review. Spanish.

PMID:
2092725
4.

Tumor infiltrating lymphocytes in HLA+ and HLA- laryngeal cancer--quantitative approach.

Dworacki G, Kruk-Zagajewska A, Jezewska E, Sikora J, Zeromski J.

Arch Immunol Ther Exp (Warsz). 1999;47(3):161-8.

PMID:
10470443
5.

[Research into the human leucocyte antigen I deletion and local lymphocytes infiltration in laryngeal carcinoma].

Niu C, Liu X, Zhou W, Jing L, Du B.

Zhonghua Er Bi Yan Hou Ke Za Zhi. 2002 Jun;37(3):215-8. Chinese.

PMID:
12772327
6.

[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].

Esteban F, Concha A, Ruiz-Cabello F, Garrido F.

Acta Otorrinolaringol Esp. 1990 Sep-Oct;41(5):297-303. Spanish.

PMID:
2076309
7.

Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

Concha A, Esteban F, Cabrera T, Ruiz-Cabello F, Garrido F.

Semin Cancer Biol. 1991 Feb;2(1):47-54.

PMID:
1912518
8.

Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.

Håkansson L, Adell G, Boeryd B, Sjögren F, Sjödahl R.

Br J Cancer. 1997;75(3):374-80.

9.

Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.

Nouri AM, Hussain RF, Oliver RT, Handy AM, Bartkova I, Bodmer JG.

Eur J Cancer. 1993;29A(13):1895-9.

PMID:
8260249
10.

Natural killer cells infiltrating colorectal cancer and MHC class I expression.

Sandel MH, Speetjens FM, Menon AG, Albertsson PA, Basse PH, Hokland M, Nagelkerke JF, Tollenaar RA, van de Velde CJ, Kuppen PJ.

Mol Immunol. 2005 Feb;42(4):541-6.

PMID:
15607811
11.

High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.

Riemersma SA, Oudejans JJ, Vonk MJ, Dreef EJ, Prins FA, Jansen PM, Vermeer MH, Blok P, Kibbelaar RE, Muris JJ, Schuuring EM, Kluin PM.

J Pathol. 2005 Jul;206(3):328-36.

PMID:
15887291
12.

Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancer.

Hosch SB, Meyer AJ, Schneider C, Stoecklein N, Prenzel KL, Pantel K, Broelsch CE, Izbicki JR.

J Gastrointest Surg. 1997 Jul-Aug;1(4):316-23.

PMID:
9834364
13.

Immunohistological characteristics of the infiltrating lymphoid cells and expression of HLA class I and II antigens in nasopharyngeal carcinoma.

Lai FM, Cheng PN, Tsao SY, Lai KN.

Virchows Arch A Pathol Anat Histopathol. 1990;417(4):347-52.

PMID:
1978435
14.

High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent.

Oudejans JJ, Harijadi H, Kummer JA, Tan IB, Bloemena E, Middeldorp JM, Bladergroen B, Dukers DF, Vos W, Meijer CJ.

J Pathol. 2002 Dec;198(4):468-75.

PMID:
12434416
15.
16.

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.

López-Nevot MA, Esteban F, Ferrón A, Gutiérrez J, Oliva MR, Romero C, Huelin C, Ruiz-Cabello F, Garrido F.

Br J Cancer. 1989 Feb;59(2):221-6.

17.

Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?

Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG, van der Burg SH, Fleuren GJ.

Clin Cancer Res. 2008 Apr 1;14(7):2028-35. doi: 10.1158/1078-0432.CCR-07-4554.

18.

Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas.

Ryschich E, Autschbach F, Eisold S, Klar E, Buchler MW, Schmidt J.

Tissue Antigens. 2003 Jul;62(1):48-54.

PMID:
12859594
19.

Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.

Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA.

Clin Cancer Res. 2000 Jul;6(7):2794-802.

20.

Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells.

Diederichsen AC, Hjelmborg Jv, Christensen PB, Zeuthen J, Fenger C.

Cancer Immunol Immunother. 2003 Jul;52(7):423-8. Epub 2003 Apr 15.

PMID:
12695859

Supplemental Content

Support Center